Refer your patients for education & observational studies
MotherToBaby welcomes the opportunity to partner with you on educating your patients about exposures during pregnancy and breastfeeding. Our teratogen information specialists can provide you and your patients with up-to-date, evidence-based information about the safety/risk of medications and other exposures in pregnancy and lactation. To fill critical information gaps, we also enroll pregnant people with select exposures into our observational research studies.
Please consider referring your patients to our exposure information service and/or our pregnancy studies research program.
Helping You Educate Your Pregnant and Breastfeeding Patients
Our experts are trained in assessing and evaluating risks to pregnancy and breastfeeding outcomes from medications and other exposures, including but not limited to maternal health conditions, infections and vaccines, substances of abuse, and workplace exposures. We conduct a thorough review of the current scientific literature to provide evidence-based information to your patients in a way they will understand. Our teratogen information specialists speak directly to patients by phone, text, email, or live-chat, and are also available to consult with you directly.
Pregnancy Studies at MotherToBaby
As an MFM, you are well-aware of the critical gaps in safety data for many medications when taken during pregnancy. We rely on our alliance with healthcare providers to advance the quality of medication safety information through patient referrals into our observational MotherToBaby Pregnancy Studies. Our rigorously designed studies aim to provide this much-needed information, ultimately helping you and your patients better navigate treatment decisions and other complex issues during pregnancy. Women self-enroll, so after you refer a patient nothing further is required from you.
You can refer pregnant patients diagnosed with the following health conditions:
- an autoimmune disease (inc. IBD, rheumatic diseases, psoriasis, atopic dermatitis, & MS)
- COVID-19 infection or vaccine exposure
Women are eligible to participate with or without current medication use.
Ready to refer your patient for exposure information or into a study? Fill out our quick form.
"*" indicates required fields
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).